(-1.57%) 5 035.69 points
(-1.49%) 37 816 points
(-2.04%) 15 658 points
(-0.63%) $81.41
(-1.81%) $1.955
(-0.03%) $2 302.30
(-0.17%) $26.61
(-0.25%) $945.80
(0.08%) $0.938
(0.18%) $11.12
(0.06%) $0.801
(0.00%) $93.45
0.00% $ 9.50
Live Chart Being Loaded With Signals
Kadmon Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes small molecules and biologics primarily for the treatment of inflammatory and fibrotic diseases...
Stats | |
---|---|
Volumen de hoy | 10.42M |
Volumen promedio | 10.03M |
Capitalización de mercado | 0.00 |
EPS | $-0.200 ( 2021-11-04 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -13.32 |
ATR14 | $0.213 (2.24%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2021-11-09 | Waksal Harlan | Sell | 177 945 | Common Stock |
2021-11-09 | Waksal Harlan | Buy | 655 000 | Stock Appreciation Right |
2021-11-09 | Waksal Harlan | Buy | 982 500 | Performance Stock Option(right to buy) |
2021-11-09 | Waksal Harlan | Buy | 1 350 000 | Stock Option (right to buy) |
2021-11-09 | Waksal Harlan | Buy | 2 000 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
0.00 |
Last 93 transactions |
Buy: 16 325 233 | Sell: 4 159 124 |
Volumen Correlación
Kadmon Holdings Inc Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Kadmon Holdings Inc Correlación - Moneda/Commodity
Kadmon Holdings Inc Finanzas
Annual | 2020 |
Ingresos: | $8.29M |
Beneficio Bruto: | $6.29M (75.86 %) |
EPS: | $-0.670 |
FY | 2020 |
Ingresos: | $8.29M |
Beneficio Bruto: | $6.29M (75.86 %) |
EPS: | $-0.670 |
FY | 2019 |
Ingresos: | $5.10M |
Beneficio Bruto: | $3.81M (74.70 %) |
EPS: | $-0.480 |
FY | 2018 |
Ingresos: | $1.40M |
Beneficio Bruto: | $714 000 (51.15 %) |
EPS: | $-0.580 |
Financial Reports:
No articles found.
Kadmon Holdings Inc
Kadmon Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes small molecules and biologics primarily for the treatment of inflammatory and fibrotic diseases. Its lead product candidates include KD025, an orally administered selective inhibitor of the rho-associated coiled-coil kinase 2, which is in Phase II clinical trial for the treatment of chronic graft-versus-host and fibrotic diseases; KD045, an oral inhibitor of ROCK for the treatment of fibrotic diseases; and KD033, an anti-PD-L1/IL-15 fusion protein for the treatment of cancer. The company also engages in developing Tesevatinib to treat autosomal dominant polycystic kidney disease; ribavirin, a nucleoside Inhibitor to treat hepatitis; and CLOVIQUE, a trientine hydrochloride capsules for the treatment of Wilson's disease. Kadmon Holdings, Inc. has strategic collaborations and license agreements with Nano Terra, Inc. and Dyax Corp. The company was founded in 2010 and is headquartered in New York, New York.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico